(Q61921686)
Statements
A Double Blind, Placebo-controlled, Dose-ranging Study to Investigate the Effect on Glycemic Control, Safety, Pharmacokinetics and Pharmacodynamics of GLP-1 in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin. (English)
0 references
February 2007
0 references
November 2007
0 references
306
0 references
18 year
0 references
75 year
0 references